End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
105 GBX | +1.94% | +2.44% | +7.36% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 926.1 | 774 | 607.4 | 977.9 | 371.7 | 408.4 |
Enterprise Value (EV) 1 | 933.9 | 785.6 | 593.4 | 979.7 | 384.3 | 426.8 |
P/E ratio | 12.6 x | -33 x | -4.75 x | 3 x | 11 x | 10.1 x |
Yield | 2.31% | 3.34% | 4.11% | 1.36% | 2.02% | 4.26% |
Capitalization / Revenue | 42.4 x | -276 x | -22 x | 11.8 x | 9.13 x | 8.6 x |
EV / Revenue | 42.8 x | -280 x | -21.5 x | 11.8 x | 9.44 x | 8.99 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | - | - | - | 16,267,119 x | 18,170,839 x |
FCF Yield | - | - | - | - | 0% | 0% |
Price to Book | 0.88 x | 0.82 x | 0.78 x | 0.86 x | 0.85 x | 0.9 x |
Nbr of stocks (in thousands) | 311,812 | 292,081 | 282,531 | 299,974 | 437,287 | 434,438 |
Reference price 2 | 0.7352 | 0.6560 | 0.5322 | 0.8070 | 0.8500 | 0.9400 |
Announcement Date | 12/06/18 | 07/06/19 | 12/06/20 | 03/06/21 | 16/06/22 | 05/06/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 21.84 | -2.808 | -27.56 | 82.99 | 40.72 | 47.48 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 19.26 | -5.232 | -29.9 | 80.7 | 36.73 | 44.7 |
Operating Margin | 88.2% | 186.32% | 108.51% | 97.24% | 90.2% | 94.13% |
Earnings before Tax (EBT) 1 | 18.31 | -5.642 | -31.34 | 80.09 | 35.7 | 41.85 |
Net income 1 | 18.15 | -5.818 | -31.86 | 80.49 | 34.06 | 40.6 |
Net margin | 83.1% | 207.19% | 115.64% | 96.98% | 83.65% | 85.5% |
EPS 2 | 0.0583 | -0.0199 | -0.1121 | 0.2690 | 0.0776 | 0.0931 |
Free Cash Flow | - | - | - | - | 23.62 | 23.49 |
FCF margin | - | - | - | - | 58.02% | 49.47% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | 69.36% | 57.85% |
Dividend per Share 2 | 0.0170 | 0.0219 | 0.0219 | 0.0110 | 0.0172 | 0.0400 |
Announcement Date | 12/06/18 | 07/06/19 | 12/06/20 | 03/06/21 | 16/06/22 | 05/06/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 7.83 | 11.6 | - | 1.81 | 12.6 | 18.4 |
Net Cash position 1 | - | - | 14 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | 23.6 | 23.5 |
ROE (net income / shareholders' equity) | 7.32% | -2.42% | -14.5% | 33.6% | 7.93% | 9.08% |
ROA (Net income/ Total Assets) | 4.27% | -1.19% | -7.36% | 18.5% | 4.84% | 5.68% |
Assets 1 | 424.5 | 487.2 | 433.1 | 434 | 704.3 | 715.3 |
Book Value Per Share 2 | 0.8400 | 0.8000 | 0.6800 | 0.9400 | 1.000 | 1.050 |
Cash Flow per Share 2 | 0.0600 | 0.0500 | 0.1400 | 0.0900 | 0.0700 | 0.0600 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 12/06/18 | 07/06/19 | 12/06/20 | 03/06/21 | 16/06/22 | 05/06/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- JEGI Stock
- Financials JPMorgan European Growth & Income plc